Information Provided By:
Fly News Breaks for June 18, 2019
SWAV
Jun 18, 2019 | 08:47 EDT
Canaccord analyst Jason Mills raised his price target on ShockWave Medical to $65 from $50 as he remains bullish due to a myriad of positive updates on the firm's proprietary IVL platform. TAVR remains the company's largest near-term opportunity but as the technology has continually improved, the percentage of TAVR cases able to be performed via a transfemoral access route has increased. Mills reiterated his Buy rating on ShockWave Medical shares.
News For SWAV From the Last 2 Days
There are no results for your query SWAV
I agree to the thefly.com's disclaimer & terms of use
About Privacy Terms of Use

© 1996-2018 TheStreet, Inc., 14 Wall Street, 15th Fl, NY, NY 10005

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.